“Pre-Filled Device Manufacturing market set to grow to $8.3bn by 2024” says new Visiongain report

02 September 2019
Pharma

Visiongain has launched a new pharma report Top Pre-Filled Injection Device Manufacturers 2019-2029: Profiles, R&D and Revenue Forecasting for Leading Syringe, Injector and Component Producers and Contract Filling Services.

Pre-filled syringes provide users with a number of advantages over other drug delivery systems. These include simplified storage and disposal, shorter preparation and administration time and reduced risk of medication errors. For drug manufacturers, there are also numerous advantages to pre-filled syringes. Filling syringes rather than vials cuts overfill rates, reducing wastage, and also eliminates material costs as there is no need for vials as well as syringes.

The lead analyst of the report commented "Most companies have invested in new manufacturing facilities or sales offices in emerging markets, to take advantage of lower cost manufacturing, as well as in order to appeal to emerging market drug developers. A particular target group among these companies are biosimilar developers looking to bring their drugs to developed markets. Companies have also invested in products suitable for administration of these biosimilars, as well as novel biologics. These include dual-chamber syringes and cartridges, lyophilisation and reconstitution tools, sensitive syringe coatings and polymer syringes."

Leading companies featured in the report include Aptar Stelmi, Becton, Dickinson, & Co (BD), Bespak Injectables, Boehringer Ingelheim, Catalent, Dätwyler Holding, Gerresheimer, Haselmeier, Laboratorios Farmacéuticos ROVI and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Medical Device Contract Manufacturing Market Report 2021-2031

Increasing demand for medical products in developing as well developed economies coupled with rising ageing population is expected to open new opportunities for medical device contract manufacturing industry over the forecast period.

01 December 2020

Read

Visiongain Publishes Virus Testing Diagnostic Kits Market Report 2021-2031

With the growing burden of rare diseases around the world, there has been a rise in the requirement for proper diagnosis as well as full proof treatment positions for various chronic diseases. With increasing awareness regarding symptoms of various terminal illnesses, the diagnosis rates have been improving in developing countries such as China, India, Japan, Brazil, and other southeast Asian countries.

01 December 2020

Read

Visiongain Publishes RNA Analysis/Transcriptomics Market Report 2020-2030

Rising preference for personalised medicine in developed as well developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase RNA analysis/transcriptomics market concentration over the forecast period. In order to increase the reliability and success rate of the drug production process.

30 November 2020

Read

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever